Not applicableUnknownNCT03525769
What this trial is testing
Screening With FibroTouch for Advanced Liver Fibrosis in NAFLD Patients With Underlying Type 2 Diabetes
Who this might be right for
Type 2 Diabetes MellitusNonalcoholic Fatty Liver Disease (NAFLD)
Nanfang Hospital, Southern Medical University 10,000